Stock Taper
OPPORTUNITY RADAR SCREENER COMPARE ANY 2 STOCKS
MDCXW
MEDICUS PHARMA LTD. COMMON STOCK
NASDAQ
$0.31
▼ DOWN 3.61% (-0.01)

KEY STATISTICS

Market Cap$6.83 M
52w High$2.50
52w Low$0.30
Dividend Yield—
Frequency—
P/E-0.15
Volume1
Shares Out.22.04M

COMPANY

LEADERSHIP

Raza Bokhari
CHIEF EXECUTIVE
Raza Bokhari

ABOUT

SECTOR
Healthcare
WENT PUBLIC
May 23, 2025
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
16

UPCOMING EARNINGS

DateNov 20, 2026
DayFriday
Rev. Est.—
NOV
20
FRI

PRICE

$0.31 ▼ DOWN 3.61% (−$0.01)
$0.30$0.30$0.31$0.319:30 AM9:31 AM9:32 AM9:33 AM9:35 AM9:36 AM9:37 AM0.31

About Medicus Pharma Ltd. Common Stock

https://medicuspharma.com ↗

Medicus Pharma Ltd., a clinical-stage biotech, advances novel therapies, with SkinJect developing a dissolvable microneedle patch for non-invasive basal cell carcinoma treatment.

INDUSTRY

Biotechnology

A PRODUCT MEDICUS PHARMA LTD. COMMON STOCK IS KNOWN FOR

SkinJect (SKNJCT-003)
SkinJect (SKNJCT-003)

SkinJect is a dissolvable microneedle patch delivering chemotherapy for basal cell carcinoma, currently in Phase 2 trials, aiming to disrupt the multi-billion dollar skin cancer treatment market.

COMPETITORS

COMPETITOR
ARQT COMPARE
BHC COMPARE
NVS COMPARE
REGN COMPARE
SNY COMPARE

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity5
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

★
OFFICER: CHIEF OPERATING OFFICER
Smith Andrew Alasdair
Purchase · 735.3K shares
2026-09-04
★
OFFICER: CHIEF OPERATING OFFICER
Smith Andrew Alasdair
Purchase · 125.0K shares
2026-09-04
★
OFFICER: CHIEF MEDICAL OFFICER
Mehmud Faisal
Purchase · 1.5M shares
2026-09-04
★
OFFICER: CHIEF MEDICAL OFFICER
Mehmud Faisal
Purchase · 250.0K shares
2026-09-04

SECTORS PEERS

PEERPRICE
SPRB$53.05COMPARE
OTLK$0.65COMPARE
CUE$37.05COMPARE
ICCC$9.95COMPARE
FBIO$2.51COMPARE
OSTX$1.77COMPARE
INKT$12.05COMPARE
NRXP$3.32COMPARE